Literature DB >> 19685637

Identifying acute HIV infection in Rhode Island.

Curt G Beckwith1, Alexandra H Cornwall, Robert Dubrow, Kimberle Chapin, Robert Ducharme, Irma Rodriguez, Lavinia Velasquez, Michael H Merson, Kathleen J Sikkema, Kenneth Mayer.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19685637      PMCID: PMC3071510     

Source DB:  PubMed          Journal:  Med Health R I        ISSN: 1086-5462


× No keyword cloud information.
  18 in total

1.  Acute HIV infection among patients tested for mononucleosis.

Authors:  E S Rosenberg; A M Caliendo; B D Walker
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

2.  Immune control of HIV-1 after early treatment of acute infection.

Authors:  E S Rosenberg; M Altfeld; S H Poon; M N Phillips; B M Wilkes; R L Eldridge; G K Robbins; R T D'Aquila; P J Goulder; B D Walker
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

3.  Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections.

Authors:  David Pao; Martin Fisher; Stephane Hué; Gillian Dean; Gary Murphy; Patricia A Cane; Caroline A Sabin; Deenan Pillay
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

4.  Heterosexual behavioral maintenance and change following HIV counseling and testing.

Authors:  Hortensia Amaro; Allison C Morrill; Jianyu Dai; Howard Cabral; Anita Raj
Journal:  J Health Psychol       Date:  2005-03

5.  Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.

Authors:  H Chakraborty; P K Sen; R W Helms; P L Vernazza; S A Fiscus; J J Eron; B K Patterson; R W Coombs; J N Krieger; M S Cohen
Journal:  AIDS       Date:  2001-03-30       Impact factor: 4.177

6.  Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

Authors:  M M Berrey; T Schacker; A C Collier; T Shea; S J Brodie; D Mayers; R Coombs; J Krieger; T W Chun; A Fauci; S G Self; L Corey
Journal:  J Infect Dis       Date:  2001-04-24       Impact factor: 5.226

7.  Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

Authors:  C Bradley Hare; Brandee L Pappalardo; Michael P Busch; Annika C Karlsson; Bruce H Phelps; Steven S Alexander; Christopher Bentsen; Clarissa A Ramstead; Douglas F Nixon; Jay A Levy; Frederick M Hecht
Journal:  Clin Infect Dis       Date:  2006-01-23       Impact factor: 9.079

8.  Detection of acute infections during HIV testing in North Carolina.

Authors:  Christopher D Pilcher; Susan A Fiscus; Trang Q Nguyen; Evelyn Foust; Leslie Wolf; Del Williams; Rhonda Ashby; Judy Owen O'Dowd; J Todd McPherson; Brandt Stalzer; Lisa Hightow; William C Miller; Joseph J Eron; Myron S Cohen; Peter A Leone
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

9.  Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion.

Authors:  Grant N Colfax; Susan P Buchbinder; Peter G A Cornelisse; Eric Vittinghoff; Kenneth Mayer; Connie Celum
Journal:  AIDS       Date:  2002-07-26       Impact factor: 4.177

10.  Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Authors:  Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W Stewart; Li-Ean Goh; Myron S Cohen
Journal:  J Infect Dis       Date:  2004-04-28       Impact factor: 5.226

View more
  2 in total

1.  Finding those at risk: acute HIV infection in Newark, NJ.

Authors:  Eugene G Martin; Gratian Salaru; Debbie Mohammed; Robert W Coombs; Sindy M Paul; Evan M Cadoff
Journal:  J Clin Virol       Date:  2013-08-13       Impact factor: 3.168

2.  Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

Authors:  Lauren E Cipriano; Gregory S Zaric; Mark Holodniy; Eran Bendavid; Douglas K Owens; Margaret L Brandeau
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.